nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—Megestrol acetate—Hydrocortisone—psoriasis	0.126	0.529	CrCrCtD
Cyproterone acetate—NR3C1—Clobetasol propionate—psoriasis	0.115	0.193	CbGbCtD
Cyproterone acetate—Medroxyprogesterone Acetate—Hydrocortisone—psoriasis	0.112	0.471	CrCrCtD
Cyproterone acetate—NR3C1—Fluocinolone Acetonide—psoriasis	0.0873	0.146	CbGbCtD
Cyproterone acetate—NR3C1—Fluocinonide—psoriasis	0.0873	0.146	CbGbCtD
Cyproterone acetate—NR3C1—Beclomethasone—psoriasis	0.0873	0.146	CbGbCtD
Cyproterone acetate—NR3C1—Triamcinolone—psoriasis	0.0348	0.0583	CbGbCtD
Cyproterone acetate—CYP19A1—Betamethasone—psoriasis	0.0329	0.0551	CbGbCtD
Cyproterone acetate—NR3C1—Betamethasone—psoriasis	0.0298	0.05	CbGbCtD
Cyproterone acetate—NR3C1—Prednisolone—psoriasis	0.0294	0.0494	CbGbCtD
Cyproterone acetate—NR3C1—Hydrocortisone—psoriasis	0.0279	0.0468	CbGbCtD
Cyproterone acetate—NR3C1—Prednisone—psoriasis	0.0278	0.0466	CbGbCtD
Cyproterone acetate—CYP19A1—Dexamethasone—psoriasis	0.0191	0.032	CbGbCtD
Cyproterone acetate—NR3C1—Dexamethasone—psoriasis	0.0174	0.0291	CbGbCtD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000602	0.0386	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000595	0.0381	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—ZMIZ1—psoriasis	0.000524	0.0336	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000488	0.0313	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—ZMIZ1—psoriasis	0.000387	0.0248	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—REL—psoriasis	0.000383	0.0246	CbGpPWpGaD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	0.000382	0.0245	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—CARM1—psoriasis	0.000378	0.0242	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CARM1—psoriasis	0.000337	0.0216	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000316	0.0203	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—VDR—psoriasis	0.000294	0.0189	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—REL—psoriasis	0.000291	0.0187	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—VDR—psoriasis	0.00029	0.0186	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—CARM1—psoriasis	0.000286	0.0184	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—CARM1—psoriasis	0.000278	0.0178	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—LEP—psoriasis	0.000277	0.0177	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP2S1—psoriasis	0.000259	0.0166	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000256	0.0164	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000254	0.0163	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CARM1—psoriasis	0.000249	0.016	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—psoriasis	0.000241	0.0155	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.00024	0.0154	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000232	0.0149	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—CAT—psoriasis	0.000224	0.0144	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—VDR—psoriasis	0.000223	0.0143	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000218	0.014	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—PPARG—psoriasis	0.000205	0.0132	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL13—psoriasis	0.000188	0.012	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000187	0.012	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000176	0.0113	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000176	0.0113	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000162	0.0104	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	0.000161	0.0103	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	0.000156	0.01	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—PPARG—psoriasis	0.000156	0.00998	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL13—psoriasis	0.000148	0.00948	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000142	0.00911	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—CD4—psoriasis	0.000137	0.00879	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL10—psoriasis	0.000133	0.00854	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL4—psoriasis	0.00013	0.00831	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—JUN—psoriasis	0.000129	0.0083	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—psoriasis	0.000128	0.00821	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000123	0.00789	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	0.000122	0.00781	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	0.000119	0.0076	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—HLA-A—psoriasis	0.000117	0.00753	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL4—psoriasis	0.000114	0.00732	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL13—psoriasis	0.000112	0.00719	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—JUN—psoriasis	0.000111	0.00715	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—STAT3—psoriasis	0.000106	0.00681	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—psoriasis	0.000103	0.00662	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—TARS—psoriasis	0.000103	0.0066	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL10—psoriasis	9.25e-05	0.00593	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	9.07e-05	0.00582	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—SOCS1—psoriasis	9.05e-05	0.0058	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—psoriasis	8.63e-05	0.00553	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—JUN—psoriasis	8.46e-05	0.00542	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—psoriasis	8.02e-05	0.00514	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	7.94e-05	0.00509	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IFNG—psoriasis	7.83e-05	0.00502	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—TARS—psoriasis	7.81e-05	0.00501	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—JUN—psoriasis	7.36e-05	0.00472	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CXCL8—psoriasis	7.28e-05	0.00467	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	7.18e-05	0.0046	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL10—psoriasis	7.02e-05	0.0045	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	6.9e-05	0.00443	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—JUN—psoriasis	6.77e-05	0.00434	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—CARM1—psoriasis	6.73e-05	0.00431	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—LEP—psoriasis	6.68e-05	0.00428	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	6.42e-05	0.00411	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—STAT3—psoriasis	6.37e-05	0.00409	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	6.03e-05	0.00387	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	6.02e-05	0.00386	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—JUN—psoriasis	5.97e-05	0.00383	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—PPARG—psoriasis	5.82e-05	0.00373	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	5.74e-05	0.00368	CbGpPWpGaD
Cyproterone acetate—Eye disorder—Prednisone—psoriasis	5.41e-05	0.00036	CcSEcCtD
Cyproterone acetate—Dyspnoea—Mycophenolate mofetil—psoriasis	5.41e-05	0.00036	CcSEcCtD
Cyproterone acetate—Decreased appetite—Cyclosporine—psoriasis	5.41e-05	0.00036	CcSEcCtD
Cyproterone acetate—Tachycardia—Hydrocortisone—psoriasis	5.39e-05	0.000359	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Cyclosporine—psoriasis	5.37e-05	0.000357	CcSEcCtD
Cyproterone acetate—Skin disorder—Hydrocortisone—psoriasis	5.37e-05	0.000357	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Dexamethasone—psoriasis	5.37e-05	0.000357	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Betamethasone—psoriasis	5.37e-05	0.000357	CcSEcCtD
Cyproterone acetate—Discomfort—Triamcinolone—psoriasis	5.36e-05	0.000357	CcSEcCtD
Cyproterone acetate—Fatigue—Cyclosporine—psoriasis	5.36e-05	0.000357	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Hydrocortisone—psoriasis	5.34e-05	0.000356	CcSEcCtD
Cyproterone acetate—Dyspepsia—Mycophenolate mofetil—psoriasis	5.34e-05	0.000356	CcSEcCtD
Cyproterone acetate—Constipation—Cyclosporine—psoriasis	5.32e-05	0.000354	CcSEcCtD
Cyproterone acetate—Renal failure—Methotrexate—psoriasis	5.3e-05	0.000353	CcSEcCtD
Cyproterone acetate—Decreased appetite—Mycophenolate mofetil—psoriasis	5.27e-05	0.000351	CcSEcCtD
Cyproterone acetate—Anorexia—Hydrocortisone—psoriasis	5.27e-05	0.000351	CcSEcCtD
Cyproterone acetate—Diarrhoea—Mycophenolic acid—psoriasis	5.26e-05	0.00035	CcSEcCtD
Cyproterone acetate—Angiopathy—Prednisone—psoriasis	5.25e-05	0.00035	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	5.24e-05	0.000349	CcSEcCtD
Cyproterone acetate—Immune system disorder—Prednisone—psoriasis	5.23e-05	0.000348	CcSEcCtD
Cyproterone acetate—Malaise—Betamethasone—psoriasis	5.22e-05	0.000347	CcSEcCtD
Cyproterone acetate—Malaise—Dexamethasone—psoriasis	5.22e-05	0.000347	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—NDUFA5—psoriasis	5.22e-05	0.00335	CbGpPWpGaD
Cyproterone acetate—Oedema—Triamcinolone—psoriasis	5.2e-05	0.000347	CcSEcCtD
Cyproterone acetate—Syncope—Dexamethasone—psoriasis	5.19e-05	0.000345	CcSEcCtD
Cyproterone acetate—Syncope—Betamethasone—psoriasis	5.19e-05	0.000345	CcSEcCtD
Cyproterone acetate—Constipation—Mycophenolate mofetil—psoriasis	5.19e-05	0.000345	CcSEcCtD
Cyproterone acetate—Sweating—Methotrexate—psoriasis	5.17e-05	0.000344	CcSEcCtD
Cyproterone acetate—Hypotension—Hydrocortisone—psoriasis	5.16e-05	0.000344	CcSEcCtD
Cyproterone acetate—Haematuria—Methotrexate—psoriasis	5.14e-05	0.000342	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Cyclosporine—psoriasis	5.12e-05	0.000341	CcSEcCtD
Cyproterone acetate—Shock—Triamcinolone—psoriasis	5.12e-05	0.000341	CcSEcCtD
Cyproterone acetate—Alopecia—Prednisone—psoriasis	5.11e-05	0.000341	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CARM1—psoriasis	5.1e-05	0.00327	CbGpPWpGaD
Cyproterone acetate—Hepatobiliary disease—Methotrexate—psoriasis	5.1e-05	0.000339	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Cyclosporine—psoriasis	5.09e-05	0.000339	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Dexamethasone—psoriasis	5.09e-05	0.000339	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Betamethasone—psoriasis	5.09e-05	0.000339	CcSEcCtD
Cyproterone acetate—Dizziness—Mycophenolic acid—psoriasis	5.08e-05	0.000338	CcSEcCtD
Cyproterone acetate—Tachycardia—Triamcinolone—psoriasis	5.08e-05	0.000338	CcSEcCtD
Cyproterone acetate—Mental disorder—Prednisone—psoriasis	5.07e-05	0.000338	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CXCL8—psoriasis	5.06e-05	0.00324	CbGpPWpGaD
Cyproterone acetate—Malnutrition—Prednisone—psoriasis	5.04e-05	0.000335	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Triamcinolone—psoriasis	5.03e-05	0.000335	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Mycophenolate mofetil—psoriasis	5e-05	0.000333	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	4.96e-05	0.00033	CcSEcCtD
Cyproterone acetate—Urticaria—Cyclosporine—psoriasis	4.94e-05	0.000329	CcSEcCtD
Cyproterone acetate—Body temperature increased—Cyclosporine—psoriasis	4.92e-05	0.000327	CcSEcCtD
Cyproterone acetate—Abdominal pain—Cyclosporine—psoriasis	4.92e-05	0.000327	CcSEcCtD
Cyproterone acetate—Vomiting—Mycophenolic acid—psoriasis	4.89e-05	0.000325	CcSEcCtD
Cyproterone acetate—Discomfort—Betamethasone—psoriasis	4.87e-05	0.000324	CcSEcCtD
Cyproterone acetate—Discomfort—Dexamethasone—psoriasis	4.87e-05	0.000324	CcSEcCtD
Cyproterone acetate—Dyspepsia—Hydrocortisone—psoriasis	4.87e-05	0.000324	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.86e-05	0.00312	CbGpPWpGaD
Cyproterone acetate—Haemoglobin—Methotrexate—psoriasis	4.86e-05	0.000324	CcSEcCtD
Cyproterone acetate—Rash—Mycophenolic acid—psoriasis	4.85e-05	0.000323	CcSEcCtD
Cyproterone acetate—Dermatitis—Mycophenolic acid—psoriasis	4.84e-05	0.000322	CcSEcCtD
Cyproterone acetate—Haemorrhage—Methotrexate—psoriasis	4.84e-05	0.000322	CcSEcCtD
Cyproterone acetate—Hepatitis—Methotrexate—psoriasis	4.84e-05	0.000322	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—JUN—psoriasis	4.82e-05	0.00309	CbGpPWpGaD
Cyproterone acetate—Urticaria—Mycophenolate mofetil—psoriasis	4.82e-05	0.000321	CcSEcCtD
Cyproterone acetate—Headache—Mycophenolic acid—psoriasis	4.82e-05	0.000321	CcSEcCtD
Cyproterone acetate—Decreased appetite—Hydrocortisone—psoriasis	4.8e-05	0.00032	CcSEcCtD
Cyproterone acetate—Body temperature increased—Mycophenolate mofetil—psoriasis	4.8e-05	0.000319	CcSEcCtD
Cyproterone acetate—Abdominal pain—Mycophenolate mofetil—psoriasis	4.8e-05	0.000319	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Hydrocortisone—psoriasis	4.77e-05	0.000318	CcSEcCtD
Cyproterone acetate—Fatigue—Hydrocortisone—psoriasis	4.77e-05	0.000317	CcSEcCtD
Cyproterone acetate—Oedema—Dexamethasone—psoriasis	4.72e-05	0.000314	CcSEcCtD
Cyproterone acetate—Oedema—Betamethasone—psoriasis	4.72e-05	0.000314	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—JUN—psoriasis	4.7e-05	0.00301	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Prednisone—psoriasis	4.68e-05	0.000311	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Prednisolone—psoriasis	4.66e-05	0.000311	CcSEcCtD
Cyproterone acetate—Visual impairment—Methotrexate—psoriasis	4.66e-05	0.00031	CcSEcCtD
Cyproterone acetate—Anaemia—Prednisone—psoriasis	4.66e-05	0.00031	CcSEcCtD
Cyproterone acetate—Shock—Dexamethasone—psoriasis	4.65e-05	0.000309	CcSEcCtD
Cyproterone acetate—Shock—Betamethasone—psoriasis	4.65e-05	0.000309	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—NFKB1—psoriasis	4.64e-05	0.00298	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Triamcinolone—psoriasis	4.64e-05	0.000309	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Betamethasone—psoriasis	4.63e-05	0.000308	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Dexamethasone—psoriasis	4.63e-05	0.000308	CcSEcCtD
Cyproterone acetate—Agitation—Prednisone—psoriasis	4.63e-05	0.000308	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Betamethasone—psoriasis	4.62e-05	0.000308	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Dexamethasone—psoriasis	4.62e-05	0.000308	CcSEcCtD
Cyproterone acetate—Tachycardia—Dexamethasone—psoriasis	4.61e-05	0.000307	CcSEcCtD
Cyproterone acetate—Tachycardia—Betamethasone—psoriasis	4.61e-05	0.000307	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Cyclosporine—psoriasis	4.58e-05	0.000305	CcSEcCtD
Cyproterone acetate—Dyspepsia—Triamcinolone—psoriasis	4.58e-05	0.000305	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Methotrexate—psoriasis	4.57e-05	0.000305	CcSEcCtD
Cyproterone acetate—Nausea—Mycophenolic acid—psoriasis	4.57e-05	0.000304	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Dexamethasone—psoriasis	4.57e-05	0.000304	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Betamethasone—psoriasis	4.57e-05	0.000304	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Hydrocortisone—psoriasis	4.55e-05	0.000303	CcSEcCtD
Cyproterone acetate—Malaise—Prednisone—psoriasis	4.54e-05	0.000303	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NFKB1—psoriasis	4.52e-05	0.0029	CbGpPWpGaD
Cyproterone acetate—Eye disorder—Methotrexate—psoriasis	4.52e-05	0.000301	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Hydrocortisone—psoriasis	4.52e-05	0.000301	CcSEcCtD
Cyproterone acetate—Syncope—Prednisone—psoriasis	4.52e-05	0.000301	CcSEcCtD
Cyproterone acetate—Anorexia—Betamethasone—psoriasis	4.5e-05	0.0003	CcSEcCtD
Cyproterone acetate—Anorexia—Dexamethasone—psoriasis	4.5e-05	0.0003	CcSEcCtD
Cyproterone acetate—Urticaria—Prednisolone—psoriasis	4.5e-05	0.000299	CcSEcCtD
Cyproterone acetate—Fatigue—Triamcinolone—psoriasis	4.49e-05	0.000299	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Mycophenolate mofetil—psoriasis	4.47e-05	0.000298	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—psoriasis	4.47e-05	0.00287	CbGpPWpGaD
Cyproterone acetate—Asthenia—Cyclosporine—psoriasis	4.46e-05	0.000297	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CYP2S1—psoriasis	4.44e-05	0.00285	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Prednisone—psoriasis	4.43e-05	0.000295	CcSEcCtD
Cyproterone acetate—Hypotension—Dexamethasone—psoriasis	4.41e-05	0.000294	CcSEcCtD
Cyproterone acetate—Hypotension—Betamethasone—psoriasis	4.41e-05	0.000294	CcSEcCtD
Cyproterone acetate—Pruritus—Cyclosporine—psoriasis	4.4e-05	0.000293	CcSEcCtD
Cyproterone acetate—Urticaria—Hydrocortisone—psoriasis	4.39e-05	0.000292	CcSEcCtD
Cyproterone acetate—Angiopathy—Methotrexate—psoriasis	4.39e-05	0.000292	CcSEcCtD
Cyproterone acetate—Immune system disorder—Methotrexate—psoriasis	4.37e-05	0.000291	CcSEcCtD
Cyproterone acetate—Body temperature increased—Hydrocortisone—psoriasis	4.37e-05	0.000291	CcSEcCtD
Cyproterone acetate—Abdominal pain—Hydrocortisone—psoriasis	4.37e-05	0.000291	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Methotrexate—psoriasis	4.36e-05	0.00029	CcSEcCtD
Cyproterone acetate—Asthenia—Mycophenolate mofetil—psoriasis	4.35e-05	0.00029	CcSEcCtD
Cyproterone acetate—Chills—Methotrexate—psoriasis	4.34e-05	0.000289	CcSEcCtD
Cyproterone acetate—Pruritus—Mycophenolate mofetil—psoriasis	4.29e-05	0.000286	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Triamcinolone—psoriasis	4.29e-05	0.000286	CcSEcCtD
Cyproterone acetate—Alopecia—Methotrexate—psoriasis	4.27e-05	0.000285	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	4.26e-05	0.000284	CcSEcCtD
Cyproterone acetate—Diarrhoea—Cyclosporine—psoriasis	4.26e-05	0.000283	CcSEcCtD
Cyproterone acetate—Discomfort—Prednisone—psoriasis	4.24e-05	0.000282	CcSEcCtD
Cyproterone acetate—Mental disorder—Methotrexate—psoriasis	4.24e-05	0.000282	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	4.21e-05	0.0027	CbGpPWpGaD
Cyproterone acetate—Malnutrition—Methotrexate—psoriasis	4.21e-05	0.00028	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Prednisolone—psoriasis	4.17e-05	0.000278	CcSEcCtD
Cyproterone acetate—Dyspepsia—Dexamethasone—psoriasis	4.16e-05	0.000277	CcSEcCtD
Cyproterone acetate—Dyspepsia—Betamethasone—psoriasis	4.16e-05	0.000277	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	4.15e-05	0.00266	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Mycophenolate mofetil—psoriasis	4.15e-05	0.000276	CcSEcCtD
Cyproterone acetate—Urticaria—Triamcinolone—psoriasis	4.13e-05	0.000275	CcSEcCtD
Cyproterone acetate—Body temperature increased—Triamcinolone—psoriasis	4.11e-05	0.000274	CcSEcCtD
Cyproterone acetate—Dizziness—Cyclosporine—psoriasis	4.11e-05	0.000274	CcSEcCtD
Cyproterone acetate—Oedema—Prednisone—psoriasis	4.11e-05	0.000274	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.11e-05	0.00263	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Dexamethasone—psoriasis	4.1e-05	0.000273	CcSEcCtD
Cyproterone acetate—Decreased appetite—Betamethasone—psoriasis	4.1e-05	0.000273	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—psoriasis	4.09e-05	0.00262	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Dexamethasone—psoriasis	4.08e-05	0.000271	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Betamethasone—psoriasis	4.08e-05	0.000271	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Hydrocortisone—psoriasis	4.07e-05	0.000271	CcSEcCtD
Cyproterone acetate—Fatigue—Dexamethasone—psoriasis	4.07e-05	0.000271	CcSEcCtD
Cyproterone acetate—Fatigue—Betamethasone—psoriasis	4.07e-05	0.000271	CcSEcCtD
Cyproterone acetate—Shock—Prednisone—psoriasis	4.05e-05	0.000269	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Prednisone—psoriasis	4.03e-05	0.000269	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—VDR—psoriasis	4.02e-05	0.00258	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Prednisone—psoriasis	4.01e-05	0.000267	CcSEcCtD
Cyproterone acetate—Dizziness—Mycophenolate mofetil—psoriasis	4.01e-05	0.000267	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	4e-05	0.00256	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	4e-05	0.00256	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Prednisone—psoriasis	3.99e-05	0.000266	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Prednisone—psoriasis	3.98e-05	0.000265	CcSEcCtD
Cyproterone acetate—Asthenia—Hydrocortisone—psoriasis	3.97e-05	0.000264	CcSEcCtD
Cyproterone acetate—Vomiting—Cyclosporine—psoriasis	3.95e-05	0.000263	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—psoriasis	3.94e-05	0.00253	CbGpPWpGaD
Cyproterone acetate—Rash—Cyclosporine—psoriasis	3.92e-05	0.000261	CcSEcCtD
Cyproterone acetate—Anorexia—Prednisone—psoriasis	3.92e-05	0.000261	CcSEcCtD
Cyproterone acetate—Dermatitis—Cyclosporine—psoriasis	3.92e-05	0.000261	CcSEcCtD
Cyproterone acetate—Pruritus—Hydrocortisone—psoriasis	3.91e-05	0.00026	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methotrexate—psoriasis	3.91e-05	0.00026	CcSEcCtD
Cyproterone acetate—Headache—Cyclosporine—psoriasis	3.9e-05	0.000259	CcSEcCtD
Cyproterone acetate—Anaemia—Methotrexate—psoriasis	3.89e-05	0.000259	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Dexamethasone—psoriasis	3.89e-05	0.000259	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Betamethasone—psoriasis	3.89e-05	0.000259	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Dexamethasone—psoriasis	3.86e-05	0.000257	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Betamethasone—psoriasis	3.86e-05	0.000257	CcSEcCtD
Cyproterone acetate—Vomiting—Mycophenolate mofetil—psoriasis	3.86e-05	0.000257	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.85e-05	0.00247	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—psoriasis	3.84e-05	0.00246	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Triamcinolone—psoriasis	3.83e-05	0.000255	CcSEcCtD
Cyproterone acetate—Rash—Mycophenolate mofetil—psoriasis	3.83e-05	0.000255	CcSEcCtD
Cyproterone acetate—Dermatitis—Mycophenolate mofetil—psoriasis	3.82e-05	0.000254	CcSEcCtD
Cyproterone acetate—Headache—Mycophenolate mofetil—psoriasis	3.8e-05	0.000253	CcSEcCtD
Cyproterone acetate—Malaise—Methotrexate—psoriasis	3.8e-05	0.000253	CcSEcCtD
Cyproterone acetate—Diarrhoea—Hydrocortisone—psoriasis	3.78e-05	0.000252	CcSEcCtD
Cyproterone acetate—Leukopenia—Methotrexate—psoriasis	3.77e-05	0.000251	CcSEcCtD
Cyproterone acetate—Urticaria—Betamethasone—psoriasis	3.75e-05	0.00025	CcSEcCtD
Cyproterone acetate—Urticaria—Dexamethasone—psoriasis	3.75e-05	0.00025	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisolone—psoriasis	3.74e-05	0.000249	CcSEcCtD
Cyproterone acetate—Asthenia—Triamcinolone—psoriasis	3.73e-05	0.000249	CcSEcCtD
Cyproterone acetate—Abdominal pain—Betamethasone—psoriasis	3.73e-05	0.000249	CcSEcCtD
Cyproterone acetate—Abdominal pain—Dexamethasone—psoriasis	3.73e-05	0.000249	CcSEcCtD
Cyproterone acetate—Body temperature increased—Dexamethasone—psoriasis	3.73e-05	0.000249	CcSEcCtD
Cyproterone acetate—Body temperature increased—Betamethasone—psoriasis	3.73e-05	0.000249	CcSEcCtD
Cyproterone acetate—Nausea—Cyclosporine—psoriasis	3.69e-05	0.000246	CcSEcCtD
Cyproterone acetate—Pruritus—Triamcinolone—psoriasis	3.68e-05	0.000245	CcSEcCtD
Cyproterone acetate—Cough—Methotrexate—psoriasis	3.67e-05	0.000245	CcSEcCtD
Cyproterone acetate—Dizziness—Hydrocortisone—psoriasis	3.65e-05	0.000243	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	3.63e-05	0.00233	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Prednisone—psoriasis	3.62e-05	0.000241	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—psoriasis	3.6e-05	0.00231	CbGpPWpGaD
Cyproterone acetate—Nausea—Mycophenolate mofetil—psoriasis	3.6e-05	0.00024	CcSEcCtD
Cyproterone acetate—Decreased appetite—Prednisone—psoriasis	3.57e-05	0.000238	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—psoriasis	3.57e-05	0.00229	CbGpPWpGaD
Cyproterone acetate—Rash—Prednisolone—psoriasis	3.57e-05	0.000238	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—JUN—psoriasis	3.57e-05	0.00229	CbGpPWpGaD
Cyproterone acetate—Dermatitis—Prednisolone—psoriasis	3.56e-05	0.000237	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.56e-05	0.000237	CcSEcCtD
Cyproterone acetate—Fatigue—Prednisone—psoriasis	3.55e-05	0.000236	CcSEcCtD
Cyproterone acetate—Headache—Prednisolone—psoriasis	3.55e-05	0.000236	CcSEcCtD
Cyproterone acetate—Discomfort—Methotrexate—psoriasis	3.54e-05	0.000236	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—psoriasis	3.52e-05	0.00226	CbGpPWpGaD
Cyproterone acetate—Constipation—Prednisone—psoriasis	3.52e-05	0.000234	CcSEcCtD
Cyproterone acetate—Vomiting—Hydrocortisone—psoriasis	3.51e-05	0.000234	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	3.49e-05	0.00224	CbGpPWpGaD
Cyproterone acetate—Rash—Hydrocortisone—psoriasis	3.48e-05	0.000232	CcSEcCtD
Cyproterone acetate—Dermatitis—Hydrocortisone—psoriasis	3.48e-05	0.000232	CcSEcCtD
Cyproterone acetate—Headache—Hydrocortisone—psoriasis	3.46e-05	0.000231	CcSEcCtD
Cyproterone acetate—Dizziness—Triamcinolone—psoriasis	3.44e-05	0.000229	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NFKB1—psoriasis	3.43e-05	0.0022	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Prednisone—psoriasis	3.39e-05	0.000226	CcSEcCtD
Cyproterone acetate—Asthenia—Dexamethasone—psoriasis	3.39e-05	0.000226	CcSEcCtD
Cyproterone acetate—Asthenia—Betamethasone—psoriasis	3.39e-05	0.000226	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methotrexate—psoriasis	3.37e-05	0.000224	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Methotrexate—psoriasis	3.37e-05	0.000224	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Prednisone—psoriasis	3.36e-05	0.000224	CcSEcCtD
Cyproterone acetate—Nausea—Prednisolone—psoriasis	3.36e-05	0.000224	CcSEcCtD
Cyproterone acetate—Pruritus—Dexamethasone—psoriasis	3.34e-05	0.000222	CcSEcCtD
Cyproterone acetate—Pruritus—Betamethasone—psoriasis	3.34e-05	0.000222	CcSEcCtD
Cyproterone acetate—Skin disorder—Methotrexate—psoriasis	3.34e-05	0.000222	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methotrexate—psoriasis	3.32e-05	0.000221	CcSEcCtD
Cyproterone acetate—Vomiting—Triamcinolone—psoriasis	3.31e-05	0.00022	CcSEcCtD
Cyproterone acetate—Nausea—Hydrocortisone—psoriasis	3.28e-05	0.000219	CcSEcCtD
Cyproterone acetate—Rash—Triamcinolone—psoriasis	3.28e-05	0.000218	CcSEcCtD
Cyproterone acetate—Dermatitis—Triamcinolone—psoriasis	3.28e-05	0.000218	CcSEcCtD
Cyproterone acetate—Anorexia—Methotrexate—psoriasis	3.28e-05	0.000218	CcSEcCtD
Cyproterone acetate—Urticaria—Prednisone—psoriasis	3.27e-05	0.000218	CcSEcCtD
Cyproterone acetate—Headache—Triamcinolone—psoriasis	3.26e-05	0.000217	CcSEcCtD
Cyproterone acetate—Abdominal pain—Prednisone—psoriasis	3.25e-05	0.000216	CcSEcCtD
Cyproterone acetate—Body temperature increased—Prednisone—psoriasis	3.25e-05	0.000216	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—CARM1—psoriasis	3.24e-05	0.00208	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Dexamethasone—psoriasis	3.23e-05	0.000215	CcSEcCtD
Cyproterone acetate—Diarrhoea—Betamethasone—psoriasis	3.23e-05	0.000215	CcSEcCtD
Cyproterone acetate—Hypotension—Methotrexate—psoriasis	3.21e-05	0.000214	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—psoriasis	3.18e-05	0.00204	CbGpPWpGaD
Cyproterone acetate—Dizziness—Dexamethasone—psoriasis	3.12e-05	0.000208	CcSEcCtD
Cyproterone acetate—Dizziness—Betamethasone—psoriasis	3.12e-05	0.000208	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—psoriasis	3.12e-05	0.002	CbGpPWpGaD
Cyproterone acetate—Nausea—Triamcinolone—psoriasis	3.09e-05	0.000206	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—psoriasis	3.09e-05	0.00198	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Methotrexate—psoriasis	3.06e-05	0.000204	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—VDR—psoriasis	3.05e-05	0.00195	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Prednisone—psoriasis	3.03e-05	0.000202	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methotrexate—psoriasis	3.03e-05	0.000201	CcSEcCtD
Cyproterone acetate—Vomiting—Dexamethasone—psoriasis	3e-05	0.0002	CcSEcCtD
Cyproterone acetate—Vomiting—Betamethasone—psoriasis	3e-05	0.0002	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.99e-05	0.00192	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Methotrexate—psoriasis	2.99e-05	0.000199	CcSEcCtD
Cyproterone acetate—Rash—Betamethasone—psoriasis	2.98e-05	0.000198	CcSEcCtD
Cyproterone acetate—Rash—Dexamethasone—psoriasis	2.98e-05	0.000198	CcSEcCtD
Cyproterone acetate—Dermatitis—Dexamethasone—psoriasis	2.97e-05	0.000198	CcSEcCtD
Cyproterone acetate—Dermatitis—Betamethasone—psoriasis	2.97e-05	0.000198	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Methotrexate—psoriasis	2.97e-05	0.000198	CcSEcCtD
Cyproterone acetate—Fatigue—Methotrexate—psoriasis	2.96e-05	0.000197	CcSEcCtD
Cyproterone acetate—Headache—Betamethasone—psoriasis	2.96e-05	0.000197	CcSEcCtD
Cyproterone acetate—Headache—Dexamethasone—psoriasis	2.96e-05	0.000197	CcSEcCtD
Cyproterone acetate—Asthenia—Prednisone—psoriasis	2.95e-05	0.000196	CcSEcCtD
Cyproterone acetate—Pruritus—Prednisone—psoriasis	2.91e-05	0.000194	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—psoriasis	2.84e-05	0.00182	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Methotrexate—psoriasis	2.83e-05	0.000189	CcSEcCtD
Cyproterone acetate—Diarrhoea—Prednisone—psoriasis	2.81e-05	0.000187	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Methotrexate—psoriasis	2.81e-05	0.000187	CcSEcCtD
Cyproterone acetate—Nausea—Betamethasone—psoriasis	2.8e-05	0.000187	CcSEcCtD
Cyproterone acetate—Nausea—Dexamethasone—psoriasis	2.8e-05	0.000187	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARG—psoriasis	2.8e-05	0.0018	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	2.74e-05	0.00176	CbGpPWpGaD
Cyproterone acetate—Urticaria—Methotrexate—psoriasis	2.73e-05	0.000182	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisone—psoriasis	2.72e-05	0.000181	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methotrexate—psoriasis	2.72e-05	0.000181	CcSEcCtD
Cyproterone acetate—Body temperature increased—Methotrexate—psoriasis	2.72e-05	0.000181	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—psoriasis	2.67e-05	0.00171	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.64e-05	0.00169	CbGpPWpGaD
Cyproterone acetate—Vomiting—Prednisone—psoriasis	2.61e-05	0.000174	CcSEcCtD
Cyproterone acetate—Rash—Prednisone—psoriasis	2.59e-05	0.000173	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisone—psoriasis	2.59e-05	0.000172	CcSEcCtD
Cyproterone acetate—Headache—Prednisone—psoriasis	2.58e-05	0.000172	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Methotrexate—psoriasis	2.53e-05	0.000169	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—psoriasis	2.49e-05	0.0016	CbGpPWpGaD
Cyproterone acetate—Asthenia—Methotrexate—psoriasis	2.47e-05	0.000164	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—CARM1—psoriasis	2.46e-05	0.00158	CbGpPWpGaD
Cyproterone acetate—Nausea—Prednisone—psoriasis	2.44e-05	0.000163	CcSEcCtD
Cyproterone acetate—Pruritus—Methotrexate—psoriasis	2.43e-05	0.000162	CcSEcCtD
Cyproterone acetate—Diarrhoea—Methotrexate—psoriasis	2.35e-05	0.000157	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.32e-05	0.00149	CbGpPWpGaD
Cyproterone acetate—Dizziness—Methotrexate—psoriasis	2.27e-05	0.000151	CcSEcCtD
Cyproterone acetate—Vomiting—Methotrexate—psoriasis	2.19e-05	0.000145	CcSEcCtD
Cyproterone acetate—Rash—Methotrexate—psoriasis	2.17e-05	0.000144	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CARM1—psoriasis	2.17e-05	0.00139	CbGpPWpGaD
Cyproterone acetate—Dermatitis—Methotrexate—psoriasis	2.16e-05	0.000144	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—psoriasis	2.15e-05	0.00138	CbGpPWpGaD
Cyproterone acetate—Headache—Methotrexate—psoriasis	2.15e-05	0.000143	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARG—psoriasis	2.12e-05	0.00136	CbGpPWpGaD
Cyproterone acetate—Nausea—Methotrexate—psoriasis	2.04e-05	0.000136	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.03e-05	0.0013	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—VDR—psoriasis	1.93e-05	0.00124	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—VDR—psoriasis	1.47e-05	0.000941	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARG—psoriasis	1.35e-05	0.000864	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAT—psoriasis	1.33e-05	0.000855	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOE—psoriasis	1.04e-05	0.000664	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARG—psoriasis	1.02e-05	0.000656	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARG—psoriasis	9.02e-06	0.000578	CbGpPWpGaD
